Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22


Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study.

Ren Y, Jiang R, Yin S, You C, Liu D, Cheng X, Tang J, Zang R.

BMC Cancer. 2015 Aug 13;15:583. doi: 10.1186/s12885-015-1525-1.


Risk stratification and outcomes of women undergoing surgery for ovarian cancer.

Patankar S, Burke WM, Hou JY, Tergas AI, Huang Y, Ananth CV, Neugut AI, Hershman DL, Wright JD.

Gynecol Oncol. 2015 Jul;138(1):62-9. doi: 10.1016/j.ygyno.2015.04.037. Epub 2015 May 11.


Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women.

Kim SI, Lee Y, Lim MC, Joo J, Park K, Lee DO, Park SY.

J Gynecol Oncol. 2015 Apr;26(2):148-54. doi: 10.3802/jgo.2015.26.2.148. Epub 2015 Jan 26.


Comparative effectiveness research in gynecologic oncology.

Patankar S, Tergas AI, Wright JD.

Cancer Treat Res. 2015;164:237-59. doi: 10.1007/978-3-319-12553-4_13.


Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer.

Suidan RS, Zhou Q, Iasonos A, O'Cearbhaill RE, Chi DS, Long Roche KC, Tanner EJ, Denesopolis J, Barakat RR, Zivanovic O.

Int J Gynecol Cancer. 2015 May;25(4):599-606. doi: 10.1097/IGC.0000000000000389.


Targeting those with decreased meaning and peace: a supportive care opportunity.

Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM.

Support Care Cancer. 2015 Jul;23(7):2025-32. doi: 10.1007/s00520-014-2568-6. Epub 2014 Dec 18.


Missed opportunities: Patterns of medical care and hospice utilization among ovarian cancer patients.

Brown AJ, Sun CC, Prescott LS, Taylor JS, Ramondetta LM, Bodurka DC.

Gynecol Oncol. 2014 Nov;135(2):244-8. doi: 10.1016/j.ygyno.2014.08.039. Epub 2014 Sep 2.


A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.

Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Mironov S, Iyer RB, Zhou Q, Iasonos A, Paul H, Hosaka M, Aghajanian CA, Leitao MM Jr, Gardner GJ, Abu-Rustum NR, Sonoda Y, Levine DA, Hricak H, Chi DS.

Gynecol Oncol. 2014 Sep;134(3):455-61. doi: 10.1016/j.ygyno.2014.07.002. Epub 2014 Jul 11.


Tertiary cytoreduction in the setting of recurrent ovarian cancer (Review).

Dogan NU, Schneider A, Chiantera V, Dogan S, Dursun P.

Oncol Lett. 2013 Sep;6(3):642-647. Epub 2013 Jul 4.


Intrathoracic gastric volvulus as a severe, delayed surgical complication after left subphrenic peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian cancer.

Caronna R, Sammartino P, Framarino ML, Sollazzo BM, Meniconi RL, Chirletti P.

World J Surg Oncol. 2013 Sep 23;11:239. doi: 10.1186/1477-7819-11-239.


TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer.

Liu T, Gao H, Chen X, Lou G, Gu L, Yang M, Xia B, Yin H.

Br J Cancer. 2013 Sep 17;109(6):1685-92. doi: 10.1038/bjc.2013.501. Epub 2013 Aug 27.


Advanced ovarian cancer: what should be the standard of care?

Goff BA.

J Gynecol Oncol. 2013 Jan;24(1):83-91. doi: 10.3802/jgo.2013.24.1.83. Epub 2013 Jan 8.


Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?

Fotopoulou C, Savvatis K, Kosian P, Braicu IE, Papanikolaou G, Pietzner K, Schmidt SC, Sehouli J.

Br J Cancer. 2013 Jan 15;108(1):32-8. doi: 10.1038/bjc.2012.544.


Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer.

Terauchi F, Okamoto A, Wada Y, Hasegawa E, Sasaki T, Akutagawa O, Sagawa Y, Nishi H, Isaka K.

Oncol Lett. 2010 Sep;1(5):861-864. Epub 2010 Sep 1.


Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute.

Marszalek A, Alran S, Scholl S, Fourchotte V, Plancher C, Rosty C, Meyniel JP, De Margerie V, Dorval T, De La Rochefordière A, Cottu P, Petrow P, Sastre-Garrau X, Salmon RJ.

Int J Surg Oncol. 2010;2010:214919. doi: 10.1155/2010/214919. Epub 2010 Jul 25.


Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.

Ang C, Chan KK, Bryant A, Naik R, Dickinson HO.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD007697. doi: 10.1002/14651858.CD007697.pub2. Review.


The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers.

Nezhat FR, DeNoble SM, Liu CS, Cho JE, Brown DN, Chuang L, Gretz H, Saharia P.

JSLS. 2010 Apr-Jun;14(2):155-68. doi: 10.4293/108680810X12785289143990.


Maximal cytoreductive effort in epithelial ovarian cancer surgery.

Shih KK, Chi DS.

J Gynecol Oncol. 2010 Jun;21(2):75-80. doi: 10.3802/jgo.2010.21.2.75. Epub 2010 Jun 30.


Feasibility and safety of extensive upper abdominal surgery in elderly patients with advanced epithelial ovarian cancer.

Lim MC, Kang S, Song YJ, Park SH, Park SY.

J Korean Med Sci. 2010 Jul;25(7):1034-40. doi: 10.3346/jkms.2010.25.7.1034. Epub 2010 Jun 17.


Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma.

Dowdy SC, Loewen RT, Aletti G, Feitoza SS, Cliby W.

Gynecol Oncol. 2008 May;109(2):303-7. doi: 10.1016/j.ygyno.2008.02.012. Epub 2008 Apr 1.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk